Status:
COMPLETED
The Effect of Inulin in Irritable Bowel Syndrome
Lead Sponsor:
Mardin Artuklu University
Conditions:
Bowel Symptoms
Depression Disorders
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
Purpose: This study was conducted to evaluate the effect of inulin on bowel symptoms, depression and quality of life in individuals with constipation-dominant irritable bowel syndrome. Individuals (n=...
Detailed Description
In the treatment of IBS, a multimodel perspective that includes psychological support (cognitive behavioural therapy, stress management techniques, etc.) in addition to lifestyle changes (dietary chan...
Eligibility Criteria
Inclusion
- the individuals were between 19-65 years of age
- volunteer to participate in the study
- Individuals diagnosed with IBS by a physician according to Rome IV criteria
Exclusion
- a history of gastrointestinal surgery (except appendectomy and cholecystectomy)
- inflammatory bowel disease
- lactose malabsorption
- gastroenteritis
- celiac disease
- gastric
- duodenal ulcer
- metabolic diseases (cardiac, hepatic and renal diseases, diabetes, etc.)
- history of malignancy
- pregnancy and lactation
- use of intestinal motility
- antidepressant drugs
- involuntary body weight loss of more than 5 kg in the last 3 months
- use of dietary fibre supplements in the last 3 months
- use of antibiotics in the last 3 months
- use of prebiotic and probiotic supplements in the last 3 months.
Key Trial Info
Start Date :
November 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06610188
Start Date
November 3 2021
End Date
April 1 2023
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mardin Artuklu University
Mardin, Turkey (Türkiye), 47200